Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 28 March 2012 | By Alexander Gaffney, RAC
A US District Court judge this week barred the US Food and Drug Administration (FDA) from importing an anesthetic drug used in executions, saying FDA's use of enforcement discretion was "callous" and "disappointing," reports Reuters.
"The FDA appears to be simply wrapping itself in the flag of law enforcement discretion to justify its authority and masquerade an otherwise seemingly callous indifference to the health consequences of those imminently facing the executioner's needle," wrote Judge Richard Leon in his 27 March decision. "How utterly disappointing!"
The ruling could have profound implications for other FDA initiatives, including its attempts to lessen drug shortages through importing unapproved methotrexate and Doxil. Regulatory Focus reported on 6 March that FDA is allowing the importation of unapproved methotrexate from Canada and the importation of supplies of Doxil-substitute Lipodox from a supplier in India.
The case also has the potential to affect several court cases involving the execution drug, known as sodium thiopental. In the last three months, suits to bar FDA from allowing the import of sodium thiopental have been filed in Tennessee, Arizona, California and Nebraska.
Neither FDA nor the Department of Justice, which represented FDA in the suit, had any comment at the time of the Reuters article's publication.
Read more:
Reuters - Judge bars import of drug used in death penalty
Regulatory Focus - US FDA Importing Unapproved Drugs to Ease Shortages
Read all Regulatory Focus Articles on Sodium Thiopental
Tags: Lipodox, Doxil, Methotrexate, Death Row, Sodium Thiopental, Import, Latest News, execution
Regulatory Focus newsletters
All the biggest regulatory news and happenings.